While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...
Pfizer's booth at the China International Import Expo in Shanghai, Nov. 7, 2024. [Photo by Wang Yiming/China.org.cn] Pfizer ...
The study compared the risk and cumulative incidence of requiring glaucoma surgery—such as minimally invasive surgery, ...
Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...
ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.
LEO Pharma has shared final results from a long-term extension study of its atopic dermatitis (AD) drug Adbry ...
Individuals who suffer from atopic dermatitis are three times more likely to develop anxiety, depression and sleep ...
The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.
The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...
Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...
First Patient Dosed in ATI-2138 Phase 2a Trial in Atopic Dermatitis As Previously Announced; Top-line Data Anticipated in First Half of 2025 – WAYNE, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Aclaris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback